WO2001098528A3 - Verfahren zum nachweis von cytosin-methylierungen - Google Patents

Verfahren zum nachweis von cytosin-methylierungen Download PDF

Info

Publication number
WO2001098528A3
WO2001098528A3 PCT/DE2001/002274 DE0102274W WO0198528A3 WO 2001098528 A3 WO2001098528 A3 WO 2001098528A3 DE 0102274 W DE0102274 W DE 0102274W WO 0198528 A3 WO0198528 A3 WO 0198528A3
Authority
WO
WIPO (PCT)
Prior art keywords
genomic dna
identifying mark
methylcytosine
dna
pcr products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DE2001/002274
Other languages
English (en)
French (fr)
Other versions
WO2001098528A2 (de
Inventor
Kurt Berlin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Epigenomics AG
Original Assignee
Epigenomics AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DE50110885T priority Critical patent/DE50110885D1/de
Priority to CA2407876A priority patent/CA2407876C/en
Priority to US10/311,661 priority patent/US7118868B2/en
Priority to EP01953113A priority patent/EP1294945B1/de
Priority to AU2001275650A priority patent/AU2001275650B2/en
Priority to IL15256901A priority patent/IL152569A0/xx
Priority to AU7565001A priority patent/AU7565001A/xx
Priority to NZ522531A priority patent/NZ522531A/en
Application filed by Epigenomics AG filed Critical Epigenomics AG
Priority to JP2002504676A priority patent/JP4489347B2/ja
Publication of WO2001098528A2 publication Critical patent/WO2001098528A2/de
Publication of WO2001098528A3 publication Critical patent/WO2001098528A3/de
Anticipated expiration legal-status Critical
Priority to US10/964,167 priority patent/US20060134643A1/en
Priority to US11/544,135 priority patent/US8241855B2/en
Priority to US12/410,389 priority patent/US7968295B2/en
Priority to US13/159,323 priority patent/US8257950B2/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6858Allele-specific amplification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2533/00Reactions characterised by the enzymatic reaction principle used
    • C12Q2533/10Reactions characterised by the enzymatic reaction principle used the purpose being to increase the length of an oligonucleotide strand
    • C12Q2533/101Primer extension

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Beschrieben wird ein Verfahren zum Nachweis von 5-Methylcytosin in genomischen DNA-Proben. Zuerst wird eine genomische DNA aus einer DNA-Probe mit einem Reagenz chemisch umgesetzt, wobei 5-Methylcytosin und Cytosin unterschiedlich reagieren. Anschliessend wird die vorbehandelte DNA unter Verwendung einer Polymerase mit Primern unterschiedlicher Sequenz amplifiziert. Im nächsten Schritt wird die amplifizierte genomische DNA auf einen Oligonukleotid Array hybridisiert und PCR-Produkte erhalten, die mit einer Markierung versehen sein müssen. Alternativ können die PCR-Produkte in einer Primer Extention Reaktion verlängert werden, wobei auch die Verlängerungsprodukte mit einer Markierung versehen sind. Im letzten Schritt werden die verlängerten Oligonukleotide auf das Vorhandensein der Markierung untersucht.
PCT/DE2001/002274 2000-06-19 2001-06-19 Verfahren zum nachweis von cytosin-methylierungen Ceased WO2001098528A2 (de)

Priority Applications (13)

Application Number Priority Date Filing Date Title
NZ522531A NZ522531A (en) 2000-06-19 2001-06-19 Method for detecting cytosine methylations
CA2407876A CA2407876C (en) 2000-06-19 2001-06-19 Method for the detection of cytosine methylations
US10/311,661 US7118868B2 (en) 2000-06-19 2001-06-19 Method for detecting cytosine methylations
EP01953113A EP1294945B1 (de) 2000-06-19 2001-06-19 Verfahren zum nachweis von cytosin-methylierungen
AU2001275650A AU2001275650B2 (en) 2000-06-19 2001-06-19 Method for detecting cytosine methylations
IL15256901A IL152569A0 (en) 2000-06-19 2001-06-19 Method for detecting cytosine methylations
AU7565001A AU7565001A (en) 2000-06-19 2001-06-19 Method for detecting cytosine methylations
DE50110885T DE50110885D1 (de) 2000-06-19 2001-06-19 Verfahren zum nachweis von cytosin-methylierungen
JP2002504676A JP4489347B2 (ja) 2000-06-19 2001-06-19 シトシン−メチル化の検出方法
US10/964,167 US20060134643A1 (en) 2000-06-19 2004-10-12 Bisulfite conversion of DNA
US11/544,135 US8241855B2 (en) 2000-06-19 2006-10-07 Method for detecting cytosine methylations
US12/410,389 US7968295B2 (en) 2000-06-19 2009-03-24 Bisulfite conversion of DNA
US13/159,323 US8257950B2 (en) 2000-06-19 2011-06-13 Bisulfite conversion of DNA

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10029915.6 2000-06-19
DE10029915A DE10029915B4 (de) 2000-06-19 2000-06-19 Verfahren zum Nachweis von Cytosin-Methylierungen

Related Child Applications (3)

Application Number Title Priority Date Filing Date
US10311661 A-371-Of-International 2001-06-19
US10/964,167 Continuation-In-Part US20060134643A1 (en) 2000-06-19 2004-10-12 Bisulfite conversion of DNA
US11/544,135 Division US8241855B2 (en) 2000-06-19 2006-10-07 Method for detecting cytosine methylations

Publications (2)

Publication Number Publication Date
WO2001098528A2 WO2001098528A2 (de) 2001-12-27
WO2001098528A3 true WO2001098528A3 (de) 2002-11-28

Family

ID=7646113

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2001/002274 Ceased WO2001098528A2 (de) 2000-06-19 2001-06-19 Verfahren zum nachweis von cytosin-methylierungen

Country Status (12)

Country Link
US (2) US7118868B2 (de)
EP (2) EP1707642A3 (de)
JP (1) JP4489347B2 (de)
AT (1) ATE338143T1 (de)
AU (2) AU7565001A (de)
CA (1) CA2407876C (de)
DE (2) DE10029915B4 (de)
DK (1) DK1294945T3 (de)
ES (1) ES2272504T3 (de)
IL (1) IL152569A0 (de)
NZ (1) NZ522531A (de)
WO (1) WO2001098528A2 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9394332B2 (en) 2002-08-29 2016-07-19 Epigenomics Ag Method for bisulfite treatment

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10010281B4 (de) * 2000-02-25 2005-03-10 Epigenomics Ag Ligase/Polymerase-Verfahren zur Detektion von Cytosin-Methylierung in DNA Proben
US20060134643A1 (en) 2000-06-19 2006-06-22 Kurt Berlin Bisulfite conversion of DNA
DE10347396B4 (de) * 2003-10-09 2005-06-23 Epigenomics Ag Optimierte Bisulfit-Umwandlung von DNA durch Einsatz von Dioxan
DE10347397B4 (de) * 2003-10-09 2005-08-04 Epigenomics Ag Optimierte Bisulfit-Umwandlung durch Zusatz von n-Alkylenglykol-Verbindungen
DE10029915B4 (de) * 2000-06-19 2005-06-16 Epigenomics Ag Verfahren zum Nachweis von Cytosin-Methylierungen
DE10347400B4 (de) * 2003-10-09 2005-08-04 Epigenomics Ag Verbesserte Bisulfit-Umwandlung von DNA durch kurzzeitige Temperaturerhöhungen
DE10347399B4 (de) * 2003-10-09 2005-09-15 Epigenomics Ag Bisulfit-Umwandlung zum Nachweis von Cytosin-Methylierungen in DNA mittels optimierter Aufreinigung
DE10154317B4 (de) * 2001-10-26 2005-06-09 Epigenomics Ag Verfahren zum Nachweis von Cytosin-Methylierungen in immobilisierten DNA Proben
US20110151438A9 (en) 2001-11-19 2011-06-23 Affymetrix, Inc. Methods of Analysis of Methylation
DE10201138B4 (de) * 2002-01-08 2005-03-10 Epigenomics Ag Verfahren zum Nachweis von Cytosin-Methylierungsmustern durch exponentielle Ligation hybridisierter Sondenoligonukleotide (MLA)
EP1340818A1 (de) * 2002-02-27 2003-09-03 Epigenomics AG Verfahren und Nukleinsäuren zur Analyse von Kolonkrebszellen
DE602004009038T3 (de) 2003-01-29 2015-06-25 Roche Diagnostics Gmbh Verbessertes Verfahren zur Behandlung durch Bisulfit
DE10338308B4 (de) 2003-08-15 2006-10-19 Epigenomics Ag Verfahren zum Nachweis von Cytosin-Methylierungen in DNA
US7262013B2 (en) * 2003-08-29 2007-08-28 Applera Corporation Bisulfite method
US7371526B2 (en) 2003-08-29 2008-05-13 Applera Corporation Method and materials for bisulfite conversion of cytosine to uracil
US7534873B2 (en) * 2003-08-29 2009-05-19 Applied Biosystems, Llc Method and materials for quaternary amine catalyzed bisulfite conversion of cytosine to uracil
CA2540310A1 (en) * 2003-10-09 2005-04-28 Epigenomics Ag Improved bisulfite conversion of dna
WO2005054502A1 (en) 2003-12-02 2005-06-16 Roche Diagnostics Gmbh Improved method for bisulfite treatment
JPWO2005100240A1 (ja) * 2004-04-08 2008-03-06 東洋紡績株式会社 Dnaの脱アミノ化のための組成物及びメチル化dnaの検出方法
US7399614B2 (en) * 2004-06-30 2008-07-15 Applera Corporation 5-methylcytosine detection, compositions and methods therefor
EP1632578A1 (de) 2004-09-03 2006-03-08 Roche Diagnostics GmbH Methode zur Dekontamination der DNA
ES2787454T3 (es) 2004-09-30 2020-10-16 Epigenomics Ag Método para proveer fragmentos de ADN derivados de una muestra archivada
US7658288B2 (en) * 2004-11-08 2010-02-09 Applied Biosystems, Llc Bisulfite conversion reagent
EP2803734B1 (de) 2005-04-01 2017-09-20 Epigenomics AG Verbesserte Bisulfit-Umwandlung von DNA
WO2006113770A1 (en) 2005-04-15 2006-10-26 Epigenomics Ag A method for providing dna fragments derived from a remote sample
US20060292585A1 (en) * 2005-06-24 2006-12-28 Affymetrix, Inc. Analysis of methylation using nucleic acid arrays
DE502005008746D1 (de) 2005-07-21 2010-02-04 Epigenomics Ag Verfahren zur Quantifizierung methylierter DNA
CA2631829C (en) 2005-12-14 2012-01-24 F. Hoffmann-La Roche Ag New method for bisulfite treatment
DE102006001161A1 (de) 2006-01-06 2007-07-12 Qiagen Gmbh Verfahren zum Nachweis von Cytosin-Methylierungen
US7820385B2 (en) * 2006-03-22 2010-10-26 The United States Of America As Represented By The Department Of Health And Human Services, Centers For Disease Control And Prevention Method for retaining methylation pattern in globally amplified DNA
US7901882B2 (en) 2006-03-31 2011-03-08 Affymetrix, Inc. Analysis of methylation using nucleic acid arrays
US20080213870A1 (en) * 2007-03-01 2008-09-04 Sean Wuxiong Cao Methods for obtaining modified DNA from a biological specimen
US8623599B2 (en) 2007-06-08 2014-01-07 Epigenomics Ag Method for methylation analysis
EP2071035A1 (de) 2007-12-13 2009-06-17 Epigenomics AG Vermittler und Verstärkungsverfahren
EP2189538A1 (de) 2008-11-21 2010-05-26 Epigenomics AG Analysemolekül und Verfahren zur Analyse einer Nucleotid-Position in einer Nukleinsäure
WO2013148147A1 (en) 2012-03-26 2013-10-03 The U.S.A., As Represented By The Secretary Dept. Of Health And Human Services Dna methylation analysis for the diagnosis, prognosis and treatment of adrenal neoplasms
US9175348B2 (en) * 2012-04-24 2015-11-03 Pacific Biosciences Of California, Inc. Identification of 5-methyl-C in nucleic acid templates
US10913986B2 (en) 2016-02-01 2021-02-09 The Board Of Regents Of The University Of Nebraska Method of identifying important methylome features and use thereof
ES2690160B2 (es) * 2017-05-17 2020-09-25 Sant Joan De Deu Hospital Método de clasificación en subgrupos moleculares de pacientes con meduloblastoma
GB2585302B (en) * 2018-02-23 2023-03-22 Emulate Inc Organs-on-chips as a platform for epigenetics discovery
US11725190B2 (en) 2019-02-22 2023-08-15 EMULATE, Inc. Microfluidic proximal tubule kidney-on-chip
DE102019118332B4 (de) 2019-07-07 2022-04-07 Ist Innuscreen Gmbh Verfahren und testkit zur bisulfitmodifizierung von dna
US20220290245A1 (en) 2019-09-11 2022-09-15 The United States Of America, As Represented By The Secretary, Department Of Health And Human Servic Cancer detection and classification
US12357843B2 (en) 2022-03-25 2025-07-15 Cutera, Inc. Methods of skin treatment with laser light
WO2025250766A1 (en) * 2024-05-29 2025-12-04 The University Of Chicago Methods and compositions for rapid detection and analysis of rna and dna modifications

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851331A (en) * 1986-05-16 1989-07-25 Allied Corporation Method and kit for polynucleotide assay including primer-dependant DNA polymerase
WO1999028498A2 (de) * 1997-11-27 1999-06-10 Epigenomics Gmbh Verfahren zur herstellung komplexer dna-methylierungs-fingerabdrücke

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506350A (en) * 1990-09-20 1996-04-09 Bittner; Michael L. Production of chromosome region specific DNA sequences and transamination
CZ298895A3 (en) * 1993-05-14 1996-04-17 Cytel Corp Compound analogous to sialyl lex, pharmaceutical composition containing thereof and process for preparing lactosammonium salt
US5786146A (en) * 1996-06-03 1998-07-28 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
US6017704A (en) * 1996-06-03 2000-01-25 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
US6117635A (en) * 1996-07-16 2000-09-12 Intergen Company Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
US6251594B1 (en) * 1997-06-09 2001-06-26 Usc/Norris Comprehensive Cancer Ctr. Cancer diagnostic method based upon DNA methylation differences
DE19853398C1 (de) * 1998-11-19 2000-03-16 Epigenomics Gmbh Verfahren zur Identifikation von Cytosin-Methylierungsmustern in genomischer DNA
US20060134643A1 (en) * 2000-06-19 2006-06-22 Kurt Berlin Bisulfite conversion of DNA
DE10029915B4 (de) * 2000-06-19 2005-06-16 Epigenomics Ag Verfahren zum Nachweis von Cytosin-Methylierungen
DE10130800B4 (de) * 2001-06-22 2005-06-23 Epigenomics Ag Verfahren zum Nachweis von Cytosin-Methylierung mit hoher Sensitivität
AU2002319756A1 (en) 2001-08-03 2003-02-17 Photon-X, Inc. System and method for the electronic control of a laser diode and thermoelectric cooler
DE10151055B4 (de) * 2001-10-05 2005-05-25 Epigenomics Ag Verfahren zum Nachweis von Cytosin-Methylierung in CpG Inseln

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851331A (en) * 1986-05-16 1989-07-25 Allied Corporation Method and kit for polynucleotide assay including primer-dependant DNA polymerase
WO1999028498A2 (de) * 1997-11-27 1999-06-10 Epigenomics Gmbh Verfahren zur herstellung komplexer dna-methylierungs-fingerabdrücke

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
ABRAVAYA KLARA ET AL: "Detection of point mutations with a modified ligase chain reaction (Gap-LCR).", NUCLEIC ACIDS RESEARCH, vol. 23, no. 4, 1995, pages 675 - 682, XP002210106, ISSN: 0305-1048 *
CLARK SUSAN J ET AL: "High sensitivity mapping of methylated cytosines.", NUCLEIC ACIDS RESEARCH, vol. 22, no. 15, 1994, pages 2990 - 2997, XP002210107, ISSN: 0305-1048 *
GONZALGO M L AND JONES P A: "Rapid quantification of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE)", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 25, no. 12, 1997, pages 2529 - 2531, XP002106409, ISSN: 0305-1048 *
HERMAN J G ET AL: "METHYLATION-SPECIFIC PCR: A NOVEL PCR ASSAY FOR METHYLATION STATUS OF CPG ISLANDS", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 93, 1 September 1996 (1996-09-01), pages 9821 - 9826, XP002910406, ISSN: 0027-8424 *
LANDEGREN U ET AL: "A LIGASE-MEDIATED GENE DETECTION TECHNIQUE", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, US, vol. 241, no. 4869, 26 August 1988 (1988-08-26), pages 1077 - 1080, XP000676556, ISSN: 0036-8075 *
PAULIN RICHARD ET AL: "Urea improves efficiency of bisulphite-mediated sequencing of 5'-methylcytosine in genomic DNA.", NUCLEIC ACIDS RESEARCH, vol. 26, no. 21, 1 November 1998 (1998-11-01), pages 5009 - 5010, XP002210104, ISSN: 0305-1048 *
WONG DAVID J ET AL: "P16-INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas.", CANCER RESEARCH, vol. 57, no. 13, 1997, pages 2619 - 2622, XP002210105, ISSN: 0008-5472 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9394332B2 (en) 2002-08-29 2016-07-19 Epigenomics Ag Method for bisulfite treatment

Also Published As

Publication number Publication date
AU7565001A (en) 2002-01-02
WO2001098528A2 (de) 2001-12-27
IL152569A0 (en) 2003-05-29
CA2407876A1 (en) 2001-12-27
JP2004500892A (ja) 2004-01-15
EP1707642A2 (de) 2006-10-04
EP1294945B1 (de) 2006-08-30
US8241855B2 (en) 2012-08-14
EP1707642A3 (de) 2006-12-27
EP1294945A2 (de) 2003-03-26
CA2407876C (en) 2012-03-20
JP4489347B2 (ja) 2010-06-23
DK1294945T3 (da) 2007-01-08
NZ522531A (en) 2005-01-28
AU2001275650B2 (en) 2005-11-03
DE10029915B4 (de) 2005-06-16
ES2272504T3 (es) 2007-05-01
DE50110885D1 (de) 2006-10-12
US7118868B2 (en) 2006-10-10
US20040152080A1 (en) 2004-08-05
ATE338143T1 (de) 2006-09-15
US20070207472A1 (en) 2007-09-06
DE10029915A1 (de) 2002-01-03

Similar Documents

Publication Publication Date Title
WO2001098528A3 (de) Verfahren zum nachweis von cytosin-methylierungen
AU4228001A (en) Method for detecting cytosine methylation in dna samples
NZ506333A (en) An assay for detecting and quantifying the presence of particular nucleic acid (DNA or RNA) sequences
AU6280599A (en) Multiplex genotyping using fluorescent hybridization probes
WO2002024056A3 (en) METHODS AND COMPOSITIONS FOR DETECTING CANCERS ASSOCIATED WITH METHYLATION OF hMLH1PROMOTER DNA
WO2003066895A3 (en) Quantitative methylation detection in dna samples
WO2001062960A3 (de) Verfahren zur detektion von cytosin-methylierung in dna proben
WO2007041342A3 (en) Labeled nucleotide analogs and uses therefor
WO1999014375A3 (en) Dna typing by mass spectrometry with polymorphic dna repeat markers
WO2003010328A3 (en) Complexity management of genomic dna
AU3064200A (en) A method of dna sequencing
WO2008011004A3 (en) Specialized oligonucleotides and their use in nucleic acid amplification and detection
WO2003016565A3 (en) Dna sequence analysis
IL147845A0 (en) Method for relative quantization of methylation of cytosin-type bases in dna samples
JP2009533066A5 (de)
WO2002031186A3 (de) Verfahren zum nachweis von cytosin-methylierungen
WO2010022098A2 (en) Dna methylation detection methods
WO2002097132A3 (en) Nucleic acid detection method
EP1178119A3 (de) Auf PCR beruhender Multiplextest zur Bestimmung des Haplotyps
WO2008061311A3 (en) Improved hybridisation of nucleic acids
WO2001029262A3 (en) Genotyping reagents, kits and methods of use thereof
WO2003072721A3 (en) Detection by sliding template amplification
WO2002061124A3 (en) Analysis of methylation patterns in genomic dna using bisulfite treatment and fluorescence polarisation assay techniques
WO2000066995A3 (en) Device for rapid dna sample processing with integrated liquid handling, thermocycling, and purification
WO2002061123A3 (en) Method of analysing dna methylation using fluorescence polarisation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 152569

Country of ref document: IL

Ref document number: 2407876

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 522531

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2001953113

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2001275650

Country of ref document: AU

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref document number: 2002 504676

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 10311661

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2001953113

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 522531

Country of ref document: NZ

WWG Wipo information: grant in national office

Ref document number: 522531

Country of ref document: NZ

WWG Wipo information: grant in national office

Ref document number: 2001275650

Country of ref document: AU

WWG Wipo information: grant in national office

Ref document number: 2001953113

Country of ref document: EP